within Pharmacolibrary.Drugs.S_SensoryOrgans.S03A_Antiinfectives.S03AA02_Tetracycline;

model Tetracycline
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.77,
    Cl = 6.166666666666667e-07,
    adminDuration = 600,
    adminMass = 500 / 1000000,
    adminCount = 1,
    Vd = 0.0013,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0006833333333333333,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Tetracycline</td></tr><tr><td>ATC code:</td><td>S03AA02</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>500</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>1.3</td><td>L</td></tr>
    <tr><td>clearance:</td><td>37</td><td>mL/min</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Tetracycline is a broad-spectrum antibiotic from the tetracycline class that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. It has been widely used for the treatment of various bacterial infections including respiratory tract infections, urinary tract infections, skin infections, and certain sexually transmitted diseases. While it is still used today, resistance has limited its application in some settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Tao, RE, et al., &amp; Feldman, SR (2023). Oral Tetracycline-Class Drugs in Dermatology: Impact of Food Intake on Absorption and Efficacy. <i>Antibiotics (Basel, Switzerland)</i> 12(7) –. DOI:<a href=\"https://doi.org/10.3390/antibiotics12071152\">10.3390/antibiotics12071152</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37508248/\">https://pubmed.ncbi.nlm.nih.gov/37508248</a></p></li><li><p>Thompson, EJ, et al., &amp; Hornik, CP (2019). Population Pharmacokinetics of Doxycycline in Children. <i>Antimicrobial agents and chemotherapy</i> 63(12) –. DOI:<a href=\"https://doi.org/10.1128/AAC.01508-19\">10.1128/AAC.01508-19</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31548185/\">https://pubmed.ncbi.nlm.nih.gov/31548185</a></p></li><li><p>Rodvold, KA, et al., &amp; Pai, MP (2020). Omadacycline: A Review of the Clinical Pharmacokinetics and Pharmacodynamics. <i>Clinical pharmacokinetics</i> 59(4) 409–425. DOI:<a href=\"https://doi.org/10.1007/s40262-019-00843-4\">10.1007/s40262-019-00843-4</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31773505/\">https://pubmed.ncbi.nlm.nih.gov/31773505</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.S.S03AA02 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Tetracycline;
